ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update

ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cell therapy company focused on ...
quiverquant

ProKidney Corp. to Host Virtual KOL Event on Rilparencel and Advanced CKD Research Following ASN Kidney Week 2026

ProKidney Corp. will host a virtual event on CKD treatment insights, featuring Dr. Katherine Tuttle discussing rilparencel.
The Tech Edvocate

Mind-Blowing Discovery: Scientists Reverse 60 Years of Aging in Human Cells

Spread the loveImagine winding back the clock, not on a dusty antique, but on your very own cells. It sounds like something ...
MarketScreener

Fractyl Health, Inc. Sharpens Focus On Revita Following Positive REMAIN-1 Pivotal Results And Advances Toward Planned FDA De Novo Submission

Fractyl Health, Inc. announced that it is sharpening its focus and concentrating its financial and operational resources on advancing Revita®, its lead product candidate, toward potential U.S. Food ...